COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT-AND-EXTEND REGIMEN: RESULTS OF THE 24-MONTH SECONDARY EFFICACY OUTCOMES FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL

被引：0
|
作者：
Hunyor, Alex P. [1 ,2 ]
Arnold, Jennifer J. [3 ]
McAllister, Ian L. [4 ]
Pecheur, Francois L. [5 ]
Heath, Ronelle-Mare [6 ]
Guymer, Robyn H. [7 ,8 ]
Gillies, Marc C. [2 ]
机构：
[1] Retina Associates, Chatswood, NSW, Australia
[2] Univ Sydney, Sydney Eye Hosp, Save Sight Inst, Macular Res Grp, Sydney, NSW, Australia
[3] Marsden Eye Specialists, Parramatta, Australia
[4] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia
[5] Healthcare Profess Grp Pty Ltd, Sydney, NSW, Australia
[6] Novotech Pty Ltd, Sydney, NSW, Australia
[7] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[8] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2018年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
S1502
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] DEVELOPMENT OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) TREATED WITH RANIBIZUMAB OR AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN: PRIMARY RESULTS FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL
    Gillies, Mark C.
    Hunyor, Alex P.
    Arnold, Jennifer J.
    Pecheur, Francois L.
    Heath, Ronelle-Mare
    Guymer, Robyn H.
    McAllister, Ian L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 118 - 118
  • [2] Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results
    Guymer, Robyn H.
    Markey, Caroline M.
    McAllister, Ian L.
    Gillies, Mark C.
    Hunyor, Alex P.
    Arnold, Jennifer J.
    OPHTHALMOLOGY, 2019, 126 (05) : 723 - 734
  • [3] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    N Homer
    D S Grewal
    R G Mirza
    A T Lyon
    M K Gill
    Eye, 2015, 29 : 1152 - 1155
  • [4] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    Homer, N.
    Grewal, D. S.
    Mirza, R. G.
    Lyon, A. T.
    Gill, M. K.
    EYE, 2015, 29 (09) : 1152 - 1155
  • [5] 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting
    Vardarinos, Athanasios
    Gupta, Nitin
    Janjua, Raazia
    Iron, Abigail
    Empeslidis, Theo
    Tsaousis, Konstantinos T.
    BMC OPHTHALMOLOGY, 2017, 17
  • [6] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial
    Mitchell, Paul
    Holz, Frank G.
    Hykin, Philip
    Midena, Edoardo
    Souied, Eric
    Allmeier, Helmut
    Lambrou, George
    Schmelter, Thomas
    Wolf, Sebastian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (09): : 1911 - 1920
  • [7] 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting
    Athanasios Vardarinos
    Nitin Gupta
    Raazia Janjua
    Abigail Iron
    Theo Empeslidis
    Konstantinos T. Tsaousis
    BMC Ophthalmology, 17
  • [8] Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease A Randomized Clinical Trial
    Kertes, Peter J.
    Galic, Ivan J.
    Greve, Mark
    Williams, Geoff
    Baker, Jason
    Lahaie, Marcel
    Sheidow, Tom
    JAMA OPHTHALMOLOGY, 2020, 138 (03) : 244 - 250
  • [9] Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’
    V P Dave
    Eye, 2015, 29 : 1630 - 1630
  • [10] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
12345